Shilpa Medicare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2025
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare has filed the notice for its 38th AGM, to be held on September 23, 2025 at 11:00 AM via video conferencing. The most significant item is a proposed 1:1 bonus share issue, capitalising about ₹9.78 crore from the securities premium to issue one bonus share for every one held, nearly doubling the paid-up equity from 9.78 crore to 19.56 crore shares. A dividend of ₹1.00 per equity share is recommended for FY25, along with adoption of FY25 audited financials. Several director re-appointments/appointments are on the agenda, including Mr. Sharath Reddy Kalakota as Whole Time Director (5 years at ~₹16.63 lakh/month) and two Independent Directors. The AGM also seeks approval to revise the remuneration of Mr. Keshav Bhutada, CEO of subsidiary Shilpa Pharma Lifesciences, to ₹1 crore per annum plus 1% commission on the subsidiary's profits.
The 1:1 bonus issue is the headline event — if approved by shareholders, it will double the share count and typically lead to a proportional price adjustment on the ex-bonus date, while the ₹1 dividend adds a modest cash return. The stock may see short-term volatility around the record date, but for long-term holders the overall economic value is unchanged.